Reach Us +441902928240


The Effect of Glucagon-like Peptide-1 (GLP-1) on Obesity

Obesity has become a major topic of medical research in the world. In addition to diet control, exercising and behavioral therapy, many scholars now believe that drug therapy should be added to the routine treatment of obesity. It is confirmed that weight-loss drugs can help improve the health of obese patients, and patients who fail to intervene in lifestyle alone can benefit from drug treatment. Glucagon-like peptide-1 (GLP-1) is currently used in clinical blood glucose control drugs, but it has been proposed that taking GLP-1 and GLP-1 analogs in obese patients can not only achieve weight loss but also prevent complications.


Xiaoyi Huang, Meihua Liang and Biyue Wei*

Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+
Flyer image

Abstracted/Indexed in

  • Index Copernicus
  • China National Knowledge Infrastructure (CNKI)
  • WorldCat
  • Geneva Foundation for Medical Education and Research
  • Secret Search Engine Labs